How much does a bottle of Venetoclax/Venetoclax cost now?

Venetoclax/Venetoclax is a selective B-cell lymphoma 2 (BCL-2) inhibitor that is now approved for several different hematologic malignancies, such as acute myeloid leukemia (AML) or chronic lymphocytic leukemia (CLL), as well as small lymphocytic lymphoma (SLL). The anti-apoptotic BCL-2 protein belongs to the apoptosis-regulating BCL-2 family. Upregulation of BCL-2 and other anti-apoptotic BCL-2 family members (such as MCL-1 or BCL-XL) helps cancer cells escape apoptosis by binding pro-apoptotic sensitizers and activators and may lead to drug resistance. In certain cancer cells that primarily rely on BCL-2 overexpression to prevent apoptosis, this is consistent with translocating venetoclax in promoting apoptosis induced by other drugs such as PIs in a clinical setting.

The original drug of Venecla has now been launched in the domestic market, providing patients with a variety of specifications to choose from. In terms of price, the price of each box of medicines varies between 1,000 yuan and 4,000 yuan depending on the specifications. It is gratifying that this drug has been included in the scope of Class B medical insurance, but it should be noted that medical insurance reimbursement is limited to patients diagnosed with adult acute myeloid leukemia.

If you consider purchasing drugs overseas, the price of the Turkish version of the original drug is slightly higher, about more than 10,000 yuan per box, containing112 100mg tablets. At the same time, there are also generic versions of Veneclac available on the market, the ingredients of which are highly similar to the original drug. For example, each box of generic drugs produced by a pharmaceutical factory in Laos contains 120 100mg tablets, and the price is only about 2,000 yuan. However, the prices of all these medicines may fluctuate due to exchange rate changes. Overall, generic drugs are more affordable.